Venture NAV Tracker / Private company
Candel Therapeutics
A publicly listed clinical-stage biopharmaceutical company and Trinity Capital borrower.
HeadquartersNeedham, MA
Founded—
Last known roundIPO2021-07 · source ↗
Reported valuation—2021-07 · source ↗
Cross-fund comparison
Current disclosed marks
One latest disclosed debt mark per fund.
| Fund | Security type | Principal | Fair value | FV / principal | Rate | Maturity | Non-accrual |
|---|---|---|---|---|---|---|---|
| TRINTrinity Capital Inc. | senior secured loan | $43.5MMar 31, 2026 · source ↗ | $42.5MMar 31, 2026 · source ↗ | 97.8%Mar 31, 2026 · source ↗ | P+3.0% (9.8% floor, 4.3% EOT)Mar 31, 2026 · source ↗ | Oct 1, 2030Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.